Renub

    Europe Pediatric Proton Therapy Market & Forecast (6 Countries Market Data), Patients Treated, Reimbursement Policies

    Excel: 4 Hours
    PDF: 4 Hours
    Jul 2017
    Pages: 108

    Get Free 10% Customization in this Report

    Europe Pediatric Proton Therapy Market has a market potential close to US$ 150 Million by 2022. The rise of pediatric cancer incidence in Europe region and proton therapy gaining prominence and credibility among radiation oncologist will motivate the investor to invest in it. As of now, the pediatric proton therapy is in growing stage in European region. There are so many robust proton therapy center-building is happening across the Europe. United Kingdom is building six proton therapy alone to cater their pediatric cancer patients.

     

    Germany has the Highest Market Share in Pediatric Proton Therapy Market 

    Germany captures highest pediatric proton therapy market share as it has launched good number of advanced proton therapy center constantly in the year 2013, 2014 and 2015. France had maximum market share in 2010 but it lost its position and reached to fourth position in 2016. The report studies pediatric proton therapy market share of these 6 countries: France, Germany, Switzerland, Sweden, Czech Republic, United Kingdom


    Rising Prevalence of Pediatric Cancer Patients and Technological Advancement will drive the Pediatric Proton Therapy Market in Europe 

    Rising overall cancer diagnosed pediatric patients in Europe will enforce the several countries in Europe to develop proton therapy center according to demand. Technological up-gradation is playing very important role in driving pediatric proton therapy market in Europe. Advanced technology & multi-room trend will cater more patients than earlier. 
      

    Europe Pediatric Proton Therapy Market & Forecast (6 Countries Market Data), Patients Treated, Reimbursement Policies is the 15th report published by Renub Research on Proton Therapy Market. This 108 page report with 71 figures and 4 Tables provides 6 Countries: Pediatric Proton Therapy Market, Proton Therapy Patient Numbers, Technology being used at these Proton Therapy Centers and Reimbursement Policies. The report also studies the Proton Therapy Sales & Forecast of four companies IBA, Varian Medical Systems, Mitsubishi, and Hitachi. 

     

    Key Questions Answered in the Report?   

        What is the Pediatric Proton Therapy Market in Europe and its growth potential in Future?
        How many pediatric patients treated by Proton Beam Therapy in Europe?
        What are the reimbursement policies for Proton Therapy across the Europe?
        What is the Pediatric Proton Therapy Market in Germany and its growth potential in Future? 
        How many Pediatric Proton Therapy Patients treated in Germany and Forecast?
        What is the Pediatric Proton Therapy Market in France and its growth potential in Future? 
        How many Pediatric Proton Therapy Patients treated in France and Forecast?
        What is the Pediatric Proton Therapy Market in Sweden and its growth potential in Future? 
        How many Pediatric Proton Therapy Patients treated in Sweden and Forecast?
        What is the Pediatric Proton Therapy Market in Switzerland and its growth potential in Future? 
        How many Pediatric Proton Therapy Patients treated in Switzerland and Forecast?
        What is the Pediatric Proton Therapy Market in Czech Republic and its growth potential in Future?
        How many Pediatric Proton Therapy Patients treated in Czech Republic and Forecast?
        What is the Pediatric Proton Therapy Market in United Kingdom and its growth potential in Future? 
        How many Pediatric Proton Therapy Patients treated in United Kingdom and Forecast?
        What Type of Technology being used at Proton Therapy Centers?


    Key Companies Proton Therapy Sales & Forecast

    1.    IBA – Sales Analysis & Forecast (2010 – 2021) 
    2.    Varian Medical Systems – Sales Analysis & Forecast (2010 – 2021) 
    3.    Mitsubishi - Sales Analysis & Forecast (2010 – 2021) 
    4.    Hitachi - Sales Analysis & Forecast (2010 – 2021) 

     

    Six Countries Covered Under this Report

    1.    France
    2.    Germany
    3.    Switzerland
    4.    Sweden
    5.    Czech Republic
    6.    United Kingdom

     

    1.    Research Findings

    2.    Europe Pediatric Proton Therapy Market (Actual & Potential)
    2.1    Europe Pediatric Proton Therapy Market

    2.2    Europe Potential Pediatric Proton Therapy Market

    3.    Europe Pediatric Proton Therapy Number of Patients (Actual & Potential)
    3.1    Europe – Pediatric Patients Treated with Proton Therapy Actual Numbers & Forecast

    3.2    Europe – Pediatric Patients with Proton Therapy Potential Numbers & Forecast

    4.    Europe Pediatric Proton Therapy Market Share by Countries

    5.    France Pediatric Proton Therapy Market – Actual & Potential Market
    5.1    France – Pediatric Proton Therapy Market & Forecast

    5.2    France – Potential Pediatric Proton Therapy Market

    6.    France Pediatric Proton Therapy Patient Number – Actual and Potential
    6.1    France – Pediatric Patients Treated with Proton Therapy Actual Numbers & Forecast

    6.2    France – Pediatric Patients with Proton Therapy Potential Numbers & Forecast

    7.    Germany Pediatric Proton Therapy Market – Actual & Potential Market
    7.1    Germany – Pediatric Proton Therapy Market & Forecast

    7.2    Germany – Potential Pediatric Proton Therapy Market

    8.    Germany Pediatric Proton Therapy Patient Number – Actual and Potential
    8.1    Germany – Pediatric Patients Treated with Proton Therapy Actual Numbers & Forecast

    8.2    Germany – Pediatric Patients with Proton Therapy Potential Numbers & Forecast

    9.    Switzerland Pediatric Proton Therapy Market – Actual & Potential Market
    9.1    Switzerland Pediatric Proton Therapy Market – Actual & Forecast

    9.2    Switzerland – Pediatric Proton Therapy Potential Market & Forecast

    10.    Switzerland Pediatric Proton Therapy Patient Number – Actual and Potential
    10.1    Switzerland – Pediatric Patients Treated with Proton Therapy Actual Numbers & Forecast

    10.2    Switzerland – Pediatric Patients with Proton Therapy Potential Numbers & Forecast

    11.    Sweden Pediatric Proton Therapy Market – Actual & Potential Market
    11.1    Sweden - Pediatric Proton Therapy Market

    11.2    Sweden – Potential Pediatric Proton Therapy Market

    12.    Sweden Pediatric Proton Therapy Patient Number – Actual and Potential
    12.1    Sweden – Pediatric Patients Treated with Proton Therapy Actual Numbers & Forecast

    12.2    Sweden – Pediatric Patients with Proton Therapy Potential Numbers & Forecast

    13.    Czech Republic Pediatric Proton Therapy Market – Actual & Potential Market
    13.1    Czech Republic Pediatric Proton Therapy Market – Actual & Forecast

    13.2    Czech Republic Potential Pediatric Proton Therapy Market & Forecast

    14.    Czech Republic Proton Therapy Patient Number – Actual and Potential
    14.1    Czech Republic – Pediatric Patients Treated with Proton Therapy Actual Numbers & Forecast

    14.2    Czech Republic – Pediatric Patients with Proton Therapy Potential Numbers & Forecast

    15.    United Kingdom Pediatric Proton Therapy Market – Actual & Potential Market
    15.1    United Kingdom Pediatric Proton therapy Market & Forecast

    15.2    United Kingdom Pediatric Proton therapy Market with NHS Expenditure

    15.3    United Kingdom Pediatric Proton Therapy Potential Market & Forecast

    16.    United Kingdom Pediatric Proton Therapy Patient Number – Actual and Potential
    16.1    United Kingdom – Patients Treated with Proton Therapy Actual Numbers & Forecast

    16.2    Treatment Patterns of Pediatric Patients with Proton Therapy in United Kingdom and Abroad

    16.3    United Kingdom – Pediatric Patients with Proton Therapy Potential Numbers & Forecast

    17.    Components of a Standard Proton Therapy Center
    17.1    Proton Accelerator
    17.1.1    Synchrotrons (example: LLUMC at Loma Linda)
    17.1.2    Cyclotrons (example: MGH Boston)
    17.1.3    Synchrocyclotrons (examples: Orsay, Uppsala)
    17.1.4    H-minus Synchrotrons
    17.1.5    Separated Sector Cyclotrons
    17.1.6    Super-conducting Cyclotrons
    17.1.7    Fast Cycling Synchrotron

    17.2    Beam Transport System

    17.3    Beam Delivery System
    17.3.1    The Passive Scattering Technique
    17.3.2    Beam Scanning

    17.4    Nozzle
    17.4.1    Single Scattering
    17.4.2    Double Scattering
    17.4.3    Uniform Scanning Nozzle
    17.4.4    Pencil Scanning Nozzle

    17.5    Treatment Planning System

    17.6    Image Viewers

    17.7    Patient Positioning System (PPS)

    17.8    Human Resource

    18.    Proton Therapy – Driving Factors
    18.1    Technology Advancement

    18.2    Rising Prevalence of Pediatric Cancer Patients in Europe

    19.    Proton Therapy – Challenges
    19.1    Requires Huge Investment

    19.2    Operations Challenges

    20.    Global Proton Therapy - Company Analysis (2010-2021)
    20.1    IBA Proton Therapy
    20.1.1    Sales Analysis
    20.1.2    IBA List of Proton Therapy Centers

    20.2    Varian Medical Systems
    20.2.1    Sales Analysis

    20.3    Mitsubishi Electric Corporation
    20.3.1    Sales Analysis
    20.3.2    Mitsubishi List of Proton Therapy Center

    20.4    Hitachi
    20.4.1    Sales Analysis
    20.4.2    Hitachi List of Proton Therapy Center

    21.    Proton Therapy – Reimbursement Policies
    21.1    Proton Therapy Reimbursement Policies for Patients

    21.2    Proton Therapy Reimbursement for Institutions, Stakeholders and Manufacturers

     


    List of Figures

    Figure 2 1: Europe – Pediatric Proton Therapy Market (Million US$), 2010 – 2016    
    Figure 2 2: Europe – Forecast for Pediatric Proton Therapy Market (Million US$), 2017 – 2021    
    Figure 2 3: Europe – Potential Pediatric Proton Therapy Market (Million US$), 2010 – 2016    
    Figure 2 4: Europe – Forecast for Potential Pediatric Proton Therapy Market (Million US$), 2017 – 2021    

    Figure 3 1: Europe – Pediatric Proton Therapy Patients (Number), 2010 – 2016    
    Figure 3 2: Europe – Forecast for Pediatric Proton Therapy Patients (Number), 2017 – 2021    
    Figure 3 3: Europe – Potential Pediatric Patient for Proton Therapy (Number), 2010 – 2016    
    Figure 3 4: Europe – Forecast for Potential Pediatric Patient for Proton Therapy (Number), 2017 – 2021    

    Figure 4 1: Europe – Pediatric Proton Therapy Market Share (Percent) by Countries, 2010 – 2016    
    Figure 4 2: Europe – Forecast for Pediatric Proton Therapy Market Share (Percent) by Countries, 2017 – 2021    

    Figure 5 1: France – Pediatric Proton Therapy Market (Million US$), 2010 – 2016    
    Figure 5 2: France – Forecast for Pediatric Proton Therapy Market (Million US$), 2017 – 2021    
    Figure 5 3: France – Potential Pediatric Proton Therapy Market (Million US$), 2010 – 2016    
    Figure 5 4: France – Forecast for Potential Pediatric Proton Therapy Market (Million US$), 2017 – 2021    

    Figure 6 1: France – Pediatric Proton Therapy Patients (Number), 2010 – 2016    
    Figure 6 2: France – Forecast for Pediatric Proton Therapy Patients (Number), 2017 – 2021    
    Figure 6 3: France – Potential Pediatric Patient for Proton Therapy (Number), 2010 – 2016    
    Figure 6 4: France – Forecast for Potential Pediatric Proton Therapy Patient (Number), 2017 – 2021    

    Figure 7 1: Germany – Pediatric Proton Therapy Market (Million US$), 2010 – 2016    
    Figure 7 2: Germany – Forecast for Pediatric Proton Therapy Market (Million US$), 2017 – 2021    
    Figure 7 3: Germany – Potential Pediatric Proton Therapy Market (Million US$), 2010 – 2016    
    Figure 7 4: Germany – Forecast for Potential Pediatric Proton Therapy Market (Million US$), 2017 – 2021    

    Figure 8 1: Germany – Pediatric Proton Therapy Patients (Number), 2010 – 2016    
    Figure 8 2: Germany – Forecast for Pediatric Proton Therapy Patients (Number), 2017 – 2021    
    Figure 8 3: Germany – Potential Pediatric Patient for Proton Therapy (Number), 2010 – 2016    
    Figure 8 4: Germany – Forecast for Potential Pediatric Proton Therapy Patient (Number), 2017 – 2021    

    Figure 9 1: Switzerland – Pediatric Proton Therapy Market (Million US$), 2010 – 2016    
    Figure 9 2: Switzerland – Forecast for Pediatric Proton Therapy Market (Million US$), 2017 – 2021    
    Figure 9 3: Switzerland – Potential Pediatric Proton Therapy Market (Million US$), 2010 – 2016    
    Figure 9 4: Switzerland – Forecast for Potential Pediatric Proton Therapy Market (Million US$), 2017 – 2021    

    Figure 10 1: Switzerland – Pediatric Proton Therapy Patients (Number), 2010 – 2016    
    Figure 10 2: Switzerland – Forecast for Pediatric Proton Therapy Patients (Number), 2017 – 2021    
    Figure 10 3: Switzerland – Potential Pediatric Patient for Proton Therapy (Number), 2010 – 2016    
    Figure 10 4: Switzerland – Forecast for Potential Pediatric Proton Therapy Patient (Number), 2017 – 2021    

    Figure 11 1: Sweden – Pediatric Proton Therapy Market (Million US$), 2011 – 2016    
    Figure 11 2: Sweden – Forecast for Pediatric Proton Therapy Market (Million US$), 2017 – 2021    
    Figure 11 3: Sweden – Potential Pediatric Proton Therapy Market (Million US$), 2010 – 2016    
    Figure 11 4: Sweden – Forecast for Potential Pediatric Proton Therapy Market (Million US$), 2017 – 2021    

    Figure 12 1: Sweden – Pediatric Proton Therapy Patients (Number), 2011 – 2016    
    Figure 12 2: Sweden – Pediatric Proton Therapy Patients (Number), 2017 – 2021  
    Figure 12 3: Sweden – Potential Pediatric Patient for Proton Therapy (Number), 2010 – 2016    
    Figure 12 4: Sweden – Forecast for Potential Pediatric Proton Therapy Patient (Number), 2017 – 2021    

    Figure 13 1: Czech Republic – Pediatric Proton Therapy Market (Million US$), 2013 – 2016    
    Figure 13 2: Czech Republic – Forecast for Pediatric Proton Therapy Market (Million US$), 2017 – 2021    
    Figure 13 3: Czech Republic – Potential Pediatric Proton Therapy Market (Million US$), 2010 – 2016    
    Figure 13 4: Czech Republic – Forecast for Potential Pediatric Proton Therapy Market (Million US$), 2017 – 2021    

    Figure 14 1: Czech Republic – Pediatric Proton Therapy Patients (Number), 2013 – 2016    
    Figure 14 2: Czech Republic – Forecast for Pediatric Proton Therapy Patients (Number), 2017 – 2021    
    Figure 14 3: Czech Republic – Potential Pediatric Proton Therapy Patients (Number), 2010 – 2016    
    Figure 14 4: Czech Republic – Forecast for Potential Pediatric Proton Therapy Patients (Number), 2017 – 2021    

    Figure 15 1: United Kingdom – Pediatric Proton Therapy Market (Million US$), 2010 – 2016    
    Figure 15 2: United Kingdom – Forecast for Pediatric Proton Therapy Market (Million US$), 2017 – 2021    
    Figure 15 3: United Kingdom – Pediatric Proton Therapy Market and NHS Expenditure (Million US$), 2010 – 2016    
    Figure 15 4: United Kingdom – Forecast for Pediatric Proton Therapy Market and NHS Expenditure (Million US$), 2010 – 2016    
    Figure 15 5: United Kingdom – Potential Pediatric Proton Therapy Market (Million US$), 2010 – 2016    
    Figure 15 6: United Kingdom – Forecast for Potential Pediatric Proton Therapy Market (Million US$), 2017 – 2021    

    Figure 16 1: United Kingdom – Pediatric Proton Therapy Patients (Number), 2010 – 2016    
    Figure 16 2: United Kingdom – Forecast for Pediatric Proton Therapy Patients (Number), 2017 – 2021    
    Figure 16 3: United Kingdom – Forecast for Proportion of Pediatric Proton Therapy Patients in U.K and Abroad (Number), 2017 – 2021    
    Figure 16 4: United Kingdom – Potential Pediatric Proton Therapy Patients (Number), 2010 – 2016    
    Figure 16 5: United Kingdom – Forecast for Potential Pediatric Proton Therapy Patients (Number), 2017 – 2021    

    Figure 18 1: Europe – Pediatric Patient Diagnosed With Cancer (Number), 2010 – 2016    
    Figure 18 2: Europe – Forecast for Pediatric Patient Cancer Incidence (Number), 2017 – 2021    

    Figure 20 1: Global – IBA Proton Therapy Sales (Million US$), 2010 – 2016    
    Figure 20 2: Global – Forecast for IBA Proton Therapy Sales (Million US$), 2017 – 2021    
    Figure 20 3: Global – Varian Medical Systems Oncology Systems Sales (Million US$), 2010 – 2016    
    Figure 20 4: Global – Forecast for Varian Medical Systems Oncology Systems Sales (Million US$), 2017 – 2021    
    Figure 20 7: Global – Mitsubishi Electric Corporation Energy and Electric Systems Sales (Million US$), 2010 – 2016    
    Figure 20 8: Global – Forecast for Mitsubishi Electric Corporation Energy and Electric Systems Sales (Million US$), 2017 – 2021    
    Figure 20 9: Global – Hitachi Electronic Systems and Equipment Sales (Million US$), 2010 – 2016    
    Figure 20 10: Global – Forecast for Hitachi Electronic Systems and Equipment Sales (Million US$), 2017 – 2021    

     

    List of Tables

    Table 15‑1: United Kingdom – Under-Construction Proton Therapy Center with Operational Launch Year


    Table 20‑1: Global – IBA Proton Therapy Centers in Operational and Under-Construction Phase
    Table 20‑2: Global – Mitsubishi Proton Therapy Centers in Operational and Under-Construction Phase
    Table 20‑3: Global – Hitachi Proton Therapy Centers in Operational and Under-Construction Phase

    Related Reports